Amarin Corp

Research Amarin Corp (AMRN) on Bullrun: market cap USD 333.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAMRN
• ExchangeNASDAQ
• CountryIreland
• SectorHealthcare
• IndustryDrug Manufacturers-General
• CurrencyUSD
• Market capUSD 333.83M
• Financial periodFY2025
• RevenueUSD 213.65M
• Revenue growth-6.5%
• Net income-USD 38.80M
• Gross margin56.6%

Valuation Snapshot

latest market cap is USD 333.83M.

About Amarin Corp

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.

Frequently asked questions

What is Amarin Corp's market cap?

Amarin Corp's market capitalization is USD 333.83M.

What does Amarin Corp do?

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.